ArrowMark Colorado Holdings’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-3,250,469
Closed -$2.61M 354
2020
Q2
$2.61M Sell
3,250,469
-115,852
-3% -$97.9K 0.03% 219
2020
Q1
$2.33M Hold
3,366,321
0.03% 212
2019
Q4
$5.32M Buy
3,366,321
+94,327
+3% +$264K 0.05% 203
2019
Q3
$13M Sell
3,271,994
-41,258
-1% -$240K 0.13% 136
2019
Q2
$24M Buy
3,313,252
+2,275,583
+219% +$15.5M 0.23% 101
2019
Q1
$6.86M Buy
1,037,669
+6
+0% +$40 0.06% 193
2018
Q4
$7.43M Buy
1,037,663
+10,048
+1% +$112K 0.08% 200
2018
Q3
$19.6M Buy
1,027,615
+36,245
+4% +$1.29M 0.16% 123
2018
Q2
$56.1M Buy
991,370
+2,901
+0.3% +$147K 0.52% 72
2018
Q1
$41.8M Sell
988,469
-542
-0.1% -$23.3K 0.42% 86
2017
Q4
$52.9M Buy
989,011
+104,399
+12% +$5.51M 0.54% 67
2017
Q3
$39.5M Buy
884,612
+120,698
+16% +$5.5M 0.45% 80
2017
Q2
$37.1M Buy
763,914
+51,947
+7% +$3.06M 0.46% 80
2017
Q1
$51.5M Buy
711,967
+62,802
+10% +$4.15M 0.7% 54
2016
Q4
$37.1M Buy
649,165
+103,598
+19% +$9.49M 0.59% 55
2016
Q3
$69.8M Buy
545,567
+76,963
+16% +$9.85M 1.27% 22
2016
Q2
$58.4M Sell
468,604
-10,955
-2% -$1.26M 1.18% 26
2016
Q1
$40.1M Buy
479,559
+126,080
+36% +$10.4M 0.89% 42
2015
Q4
$35M Buy
353,479
+64,524
+22% +$6.92M 0.96% 27
2015
Q3
$35.4M Sell
288,955
-57,523
-17% -$7.81M 0.97% 32
2015
Q2
$53.1M Buy
346,478
+31,450
+10% +$5.19M 1.3% 21
2015
Q1
$53.8M Buy
315,028
+29,607
+10% +$4.49M 1.39% 15
2014
Q4
$43.6M Buy
285,421
+18,461
+7% +$2.3M 1.12% 24
2014
Q3
$28.3M Buy
266,960
+15,505
+6% +$2.16M 0.78% 43
2014
Q2
$38.2M Buy
251,455
+118,482
+89% +$15.8M 1.09% 19
2014
Q1
$17.1M Buy
132,973
+4,369
+3% +$679K 0.56% 68
2013
Q4
$22.4M Sell
128,604
-16,211
-11% -$2.79M 0.7% 49
2013
Q3
$23.4M Buy
144,815
+139,415
+2,582% +$22M 0.77% 46
2013
Q2
$717K Buy
+5,400
New +$762K 0.19% 73

Other funds holding ELGX

ArrowMark Colorado Holdings's ELGX Position: Q3 2020 in Review

ArrowMark Colorado Holdings sold out of Endologix Inc (ELGX) in Q3 2020, closing a stake of 3,250,469 shares — an estimated $2.61M sold.

ArrowMark Colorado Holdings first reported a position in ELGX in Q2 2013 and held it in 29 quarters. The position peaked at $69.8M in Q3 2016. 6 funds tracked by Wall St. Rank hold ELGX as of Q3 2020.

  • ArrowMark Colorado Holdings reported no remaining Endologix Inc position as of Q3 2020 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 3,250,469 Endologix Inc shares in Q3 2020, an estimated $2.61M.
  • ArrowMark Colorado Holdings first reported a position in Endologix Inc in Q2 2013 and held it in 29 quarters.
  • ArrowMark Colorado Holdings's Endologix Inc position peaked at $69.8M in Q3 2016.
  • 6 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2020.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.